. . . "Source: FDA, Parexel Pharmaceutical Industry R & D Source Book, 2004/2005, as shown in Graham [55].This, however, is not to say that Bayh-Dole was the most desirable thing to happen to the people, particularly the patients, in US Even though it is not our intention here to discuss the Act in any greater detail than what has been necessary, it need be mentioned here that among its various adverse i" .